AI agent selects gene therapy and injects live mouse brain autonomously

A biotech startup has deployed an artificial intelligence agent to conduct surgery on a live mouse brain without human intervention12. The Claude model independently selected a gene therapy drug, pinpointed the brain target, and calculated the injection coordinates before administering the treatment12.

What we know, and what we don't

The operation was performed on an epileptic mouse1. According to lead researcher Ocana-Santero, the trial represents the first time an autonomous software agent has executed this kind of procedure on its own1.

Both outlets confirm that the agent completed the physical injection and the therapeutic selection12. The reports leave open which startup hosted the research, as well as whether the injected therapy succeeded in halting seizures12.

Why it matters

The experiment highlights a transition toward automated laboratory workflows where software directs physical medical interventions rather than only processing data2. This capability could alter the way research facilities conduct preclinical biomedical studies2.